XML 27 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 6 - Stock-based Compensation
12 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

NOTE
6.
STOCK-BASED COMPENSATION
Stock Option Plan

     Our
2000
Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options
may
be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a
five
-year period. The options have exercisable lives ranging from
one
year to
ten
years from the date of grant, and are generally
not
eligible to vest early in the event of retirement, death, disability, or change in control. Exercise prices are
not
less than fair market value of the underlying Common Stock at the date the options are granted. Stock-based compensation expense was
$40,920
in fiscal
2018,
$22,000
in fiscal
2017,
and
$21,160
in fiscal
2016.


Valuation assumptions

     We use the Black-Scholes standard option-pricing model to determine the fair value of stock options. The following assumptions were used to estimate the fair value of options granted:
 
   
Year Ended March 31
 
   
2018
   
2017
   
2016
 
Risk-free interest rate
   
1.8
%
   
1.0
%
   
1.6
%
Expected volatility
   
28
%
   
27
%
   
26
%
Expected life (years)
   
4.4
     
4.3
     
4.3
 
Dividend yield
   
5.3
%
   
7.0
%
   
7.1
%
 
     The determination of the fair value of the awards on the date of grant using the Black-Scholes model is affected by our stock price as well as assumptions of other variables, including projected stock option exercise behaviors, risk-free interest rate, and expected volatility of our stock price in future periods. Our estimates and assumptions affect the amounts reported in the financial statements and accompanying notes.

Expected life

     We analyze historical exercise and termination data to estimate the expected life assumption. We believe historical data currently represents the best estimate of the expected life of a new option.

Risk-free interest rate

     The risk-free rate is based on the yield of U.S. Treasury securities on the grant date for maturities similar to the expected lives of the options.

Volatility

     We use historical volatility to estimate the expected volatility of our common stock.

Dividend yield

     We assumed a dividend yield of
5.3%
for fiscal
2018,
7.0%
for fiscal
2017,
and
7.1%
for fiscal
2016
based on the dividend yield on the date the options were granted.

Tax effects of stock-based compensation

     Stock-based compensation increased deferred tax assets by
$8,953
for fiscal
2018
and
$7,993
for fiscal
2017.

 

General stock option information

     We had
no
nonvested shares as of
March 
31,
2018
or
2017.
The following table summarizes information about options outstanding as of
March 
31,
2018,
all of which were exercisable:
 
Ranges of
Exercise Prices
   
Number
Outstanding
   
Weighted Average
Exercise Price
   
Weighted Remaining
Contractual Life (years)
 
$42.45
-
54.11
     
4,000
    $
49.37
     
3.4
 
 56.76
-
76.13
     
18,000
     
63.81
     
7.4
 
 
 
 
     
22,000
    $
61.19
     
6.6
 
 
     Our
2000
Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options
may
be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a
five
-year period. The options have exercisable lives ranging from
one
year to
ten
years from the date of grant. Exercise prices are
not
less than fair market value as determined by our Board at the date the options are granted.

     A summary of our stock options is shown in the following table:
 
   
Option Shares
Reserved
   
Options
Outstanding
   
Weighted Average
Option Exercise Price
 
At March 31, 2015
   
151,230
     
35,090
    $
33.51
 
Granted
   
(4,000
)
   
4,000
    $
56.76
 
Exercised
   
-
     
(18,090
)
  $
16.19
 
At March 31, 2016
   
147,230
     
21,000
    $
52.85
 
Granted
   
(4,000
)
   
4,000
    $
57.46
 
Exercised
   
-
     
(6,000
)
  $
41.19
 
At March 31, 2017
   
143,230
     
19,000
    $
57.51
 
Granted
   
(4,000
)
   
4,000
    $
76.13
 
Exercised
   
-
     
(1,000
)
  $
51.04
 
At March 31, 2018
   
139,230
     
22,000
    $
61.19
 
 
     The remaining weighted-average exercisable life was
6.6
 years as of
March 
31,
2018,
6.8
 years as of
March 
31,
2017;
and
6.2
 years as of
March 
31,
2016.
All outstanding options were exercisable as of
March 
31,
2018,
2017,
and
2016.
The total intrinsic value of options exercised during fiscal
2018
was
$34,850
based on the difference between the exercise price and stock price at the time of exercise for in-the-money options. The total intrinsic value of options outstanding
March 
31,
2018,
based on our closing stock price for that day, was
$482,300,
all of which was exercisable. The total fair value of option grants was
$40,920
in fiscal
2018.
There was
no
unrecognized stock-based compensation as of
March 
31,
2018.